September 24, 2021

Global Antibacterial Drugs Market Is Expected To Reach USD 5,056.3 Mn By 2022

3 min read

The latest market report published by Acute Market Reports “Global Antibacterial Drugs Market – Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2016 – 2022,” the antibacterial drugs market was valued at USD 42,232.2 Mn in 2015, and is expected to reach USD 45,909.4 Mn by 2022, expanding at a CAGR of 1.15% from 2016 to 2022.

Browse the full report Antibacterial Drugs Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at https://www.acutemarketreports.com/report/antibacterial-drugs-market

Market Insights

Antibacterial drugs are derived from bacteria or molds or are synthesized de novo. These drugs treat infectious diseases caused by gram positive, gram negative, aerobic and anaerobic bacteria that cannot be treated by any other method unlike other diseases. Antibacterial drugs have several mechanisms of action, including inhibiting cell wall synthesis, increasing cell membrane permeability, interfering with protein synthesis, nucleic acid metabolism, and other metabolic processes. The alarming antibacterial-resistance crisis has penetrated the awareness of clinicians, researchers, policymakers, governments and the public at large. The key factors assisting the growth of antibacterial drugs market are mounting prevalence of infectious diseases, government support, and increased research and development activities. However, evolving drug-resistant species, launch of generics, and upcoming patent expirations are anticipated to restrict the growth of the global market through 2022. Globally, the rise in geriatric population is also being considered as one of the key growth factors as it will indirectly increase the demand for various antibacterial drugs. The demand for antibacterial drugs will continue to rise mainly due to increased prevalence of resistant species that demand development of innovative molecules.

Pipeline Analysis

The phase III drugs included in the pipeline analysis are solithromycin (Cempra, Inc.), VivaGel/ SPL7013 (Starpharma Holdings Limited), surotomycin (Merck & Co.), MK-3415A (Merck & Co.) and others. According to market experts, these upcoming drugs assure to provide enhanced efficacy, shorter onset of action and fewer side effects as compared to the currently available antibacterial drugs. Thus, future commercialization of these drugs during the forecast period 2016 – 2022 is anticipated to have a reflective impact on the growth of the overall antibacterial drugs market.

Key Market Movements:

  • Asia Pacific presently dominates the overall market and is also projected to experience the fastest growth throughout the forecast period
  • The rising incidence and prevalence of antibacterial drug resistance bacteria strains such as Methicillin-resistant Staphylococcus aureus (MRSA)
  • Stringent regulatory policies applied by FDA and other government agencies across the world is expected to reduce the risk of infection outbreak in hospitals
  • Novel and developed treatments in pipeline are expected to assist the overall market growth of antibacterial drugs market

 

Key questions answered in this report

  • What are the current market trends and dynamics in the antibacterial drugs market and valuable opportunities for emerging players?
  • Estimated forecast and market projections up to 2029
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which is the largest regional market for antibacterial drugs?
  • What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • The worldwide market value of the antibacterial drugs market in 2019 and 2020
  • Which are the key trends driving the global antibacterial drugs market growth?
  • Who are the leading service providers in the antibacterial drugs market worldwide?

About Acute Market Reports

Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.

Contact Info.:-

Address: 90 Church St, FL 1 #3514,
New York, NY 10008
United States
Email: [email protected]
Toll Free(US/CANADA): +1-855-455-8662
Website: https://www.acutemarketreports.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © All rights reserved. | Newsphere by AF themes.